/
/
/

Asston Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Open (₹)138.00
Volume (₹)50,000.00
High (₹)149.80
Upper Circuit150.20
Low (₹)135.90
Lower Circuit135.90
Prev Close143.05
52W High (₹)153.40
Price137.95
52W Low (₹)60.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)156.25 Cr
Div. Yield (%)0.00
PE Ratio40.44
Debt to Equity0.68
Price to Book0.00
Book Value17.09
EPS (TTM)3.54
Face Value10.00
ROE (%)50.56

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
APL-MTNSE
LTP
1W Low
1W High
Market cap (₹)
1776-2.25 (-0.13%)
1720.80
1809.65
4,25,150Cr
10036+321 (3.30%)
9866.35
10080.20
2,66,265Cr
4730+94.85 (2.05%)
4555
4730
1,76,301Cr
2306.1-85.9 (-3.59%)
2252.50
2442
1,25,352Cr
1190-54 (-4.34%)
1182.05
1266.15
1,23,591Cr
1372+21.8 (1.61%)
1337.30
1390.70
1,14,351Cr
1400.1+20.1 (1.46%)
1364.75
1400.60
1,12,474Cr
2533.15+44.4 (1.78%)
2457.35
2539
1,02,315Cr
1701.1+23.3 (1.39%)
1656.90
1724.50
97,757Cr
2015+6 (0.30%)
1989.10
2061.55
92,007Cr
137.95-12.77 (-8.47%)
135.90
153
156Cr

Key Highlights of Asston Pharmaceuticals Ltd’s P&L

In 2025-03-31, Asston Pharmaceuticals Ltd reported total revenue of ₹25.04Cr, compared with ₹15.59Cr in 2024-03-31, reflecting Asston Pharmaceuticals Ltd turnover.

Depreciation was ₹8.1Lakh and finance costs were ₹94.97Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹5.7Cr in 2025-03-31 as compared to ₹1.82Cr in 2024-03-31.

Net Profit (PAT) was ₹4.33Cr in 2025-03-31 compared with ₹1.36Cr in 2024-03-31.

Earnings per share (EPS) were ₹6.90 in 2025-03-31, compared with ₹17.35 in 2024-03-31.